Answers are grounded in this paper and cite their sources.
Evidence from animal studies suggests that minocycline may reduce lobar intracerebral hemorrhage (ICH) recurrence in cerebral amyloid angiopathy, possibly by inhibiting perivascular extracellular matrix degradation in cerebral small vessels. There is currently no evidence of its safety or efficacy in humans with cerebral amyloid angiopathy.
No takes yet. Share an insight, caveat, or question.
Bax et al. (2024) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: